NeoPharm Co. Ltd.
092730.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$365.22B
Close$
$46712.41
100.1% upside
Current Fair Value
100.1% upsideUndervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $365.22 Billion |
|---|---|
| Enterprise Value | $342.59 Billion |
| Dividend Yield | $600.00 (2.57%) |
| Earnings per Share | $1778.81 |
| Beta | 0.17 |
| Outstanding Shares | 16,028,000 |
Return
| Return on Equity | 15.25% |
|---|---|
| Return on Assets | 13.55% |
| Return on Invested Capital | 18.19% |
Valuation & Multiples
| P/E Ratio | 11.92 |
|---|---|
| PEG | 62.94 |
| Price to Sales | 2.52 |
| Price to Book Ratio | 1.86 |
| Enterprise Value to Revenue | 2.31 |
| Enterprise Value to EBIT | 9.33 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$43.60 B
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$42.00 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NeoPharm Co. Ltd.
141 employees
CEO: Kim Yang-soo Established on July 1, 2000, NeoPharm Co., Ltd. is a Daejeon, South Korea-based company that develops, produces, and markets a diverse range of cosmetic, medical, and health products. Its offerings notably include advanced skincare formu...